πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10392376

Heterocyclic inhibitors of ATR kinase

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10392618

Micro-RNA family that modulates extracellular matrix genes and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10391093

Therapeutic compounds

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10392642

High molecular weight heparosan polymers and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10383943

Compositions and related methods for the treatment of cancer

SOUTH DAKOTA BOARD OF REGENTS Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10385080

STAT6 inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10383940

Copper-cysteamine and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10377796

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10376574

Compositions and methods for vaccination against influenza A virus

SOUTH DAKOTA BOARD OF REGENTS Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10378058

Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10379109

Systems and methods for high-resolution imaging

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10370419

Tuberculosis vaccine compositions and related methods

THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXTAS SYSTEM Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10370679

Modified immunization vectors

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10369103

Neuroprotective liposome compositions and methods for treatment of stroke

The Board of Regents of the University of Texas System Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10370360

Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363311

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

The Board of Regents of the University of Texas System Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363319

Glycoconjugates and methods for their use

The Board of Regents of the University of Texas System Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363282

Analogs of C5a and methods of using same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10364227

Therapeutic compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363245

Methods for treating CNS lesions

The Board of Regents of the University of Texas System Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363261

Enolase inhibitors and methods of treatment therewith

The Board of Regents of the University of Texas System Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363248

Salts of heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10358501

HER3 specific monoclonal antibodies for diagnostic and therapeutic use

The Board of Regents of the University of Texas System Β· Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10358419

1,3-dipolar [70]fulleropyrrolidinium iodide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted